Xeomin 100 UT vial 1S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUDT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,214
Award facts
- Contract value 100% obligated
- $25,214.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,214.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 23, 2026, for the supply of XEOMIN 100 Unit vials. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 12, 2026. XEOMIN is a botulinum toxin therapeutic commonly used for medical and cosmetic applications, and this procurement supports DLA's mission to provide comprehensive pharmaceutical and medical supply chain services to military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, operates as a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen). The company serves as a critical federal vendor supplying an extensive portfolio of prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies the types of competitive, firm fixed-price pharmaceutical procurements that DLA routinely executes through its prime vendor contracts to support Defense Health Agency operations, military treatment facilities, and other federal healthcare institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26FAUDT?
SPE2DR26FAUDT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FAUDT worth?
The government has obligated $25,214 on SPE2DR26FAUDT.
Is contract SPE2DR26FAUDT an order under another contract?
Yes. SPE2DR26FAUDT is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUDT competed?
The extent of competition for SPE2DR26FAUDT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award